CHTR
Charter Communications, Inc.
CHTR trails on the overall score without a compensating advantage in the available component scores.
META
Meta Platforms, Inc.
META has the edge over CHTR overall, supported by stronger modeled upside and lower modeled downside.
CHTR Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Weak |
CHTR's revenue, profitability and cash flow are currently stable, but its balance sheet is weak.
META Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
META's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
CHTR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 3.1x | $133 | — |
| Cheap | 7.3x | $69.62 | -48% |
| Fair | 12x | $118 | -11% |
| Current | 14x | $133 | — |
| Expensive | 42x | $404 | +205% |
Historical ranges are pointers, not guarantees.
CHTR's PE is in its fair range at 14x. If earnings grow as analysts expect, today's price would be 3.1x next year's earnings, in its cheap range.
META PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 19x | $624 | — |
| Cheap | 21x | $613 | -1.7% |
| Current | 21x | $624 | — |
| Fair | 27x | $803 | +29% |
| Expensive | 32x | $934 | +50% |
Historical ranges are pointers, not guarantees.
META has the edge over CHTR in the historical PE scenario, which offers more potential upside but is not a forecast.
CHTR Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Strongly weakening | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CHTR, but weaker profitability. However, they disagree widely on these estimates.
META Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for META, but weaker profitability. However, they disagree widely on these estimates.
CHTR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $42.65 | +344% |
| Q3 2026 | $9.60 | -73% |
| Q2 2026 | $38.44 | +5.2% |
| Q1 2026 | $36.96 | +3.1% |
| Q4 2025 | $36.21 | +3.5% |
| Q3 2025 | $36.05 | +13% |
| Q2 2025 | $36.53 | +17% |
| Q1 2025 | $35.84 | +16% |
| Q4 2024 | $34.97 | +17% |
CHTR earned $9.60 per share over the past year, down 73% from the year before.
META Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $32.16 | +9.7% |
| Q3 2026 | $29.32 | +30% |
| Q2 2026 | $26.54 | -3.7% |
| Q1 2026 | $27.50 | +7.5% |
| Q4 2025 | $23.49 | -1.6% |
| Q3 2025 | $22.58 | +6.5% |
| Q2 2025 | $27.56 | +41% |
| Q1 2025 | $25.58 | +47% |
| Q4 2024 | $23.86 | +60% |
META earned $29.32 per share over the past year, up 30% from the year before.
CHTR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $14.9B | +9.1% |
| Q2 2026 | $13.5B | -1.7% |
| Q1 2026 | $13.6B | -1% |
| Q4 2025 | $13.6B | -2.3% |
| Q3 2025 | $13.7B | -0.9% |
| Q2 2025 | $13.8B | +0.6% |
| Q1 2025 | $13.7B | +0.4% |
| Q4 2024 | $13.9B | +1.6% |
CHTR's revenue grew through 2021 and has held roughly level since: $14.9B last quarter, up 9.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -24% | -47 points |
| Q2 2026 | 23% | -1.2 points |
| Q1 2026 | 24% | 0 points |
| Q4 2025 | 24% | -0.4 points |
| Q3 2025 | 23% | -1.3 points |
| Q2 2025 | 24% | 0 points |
| Q1 2025 | 24% | +0.7 points |
| Q4 2024 | 24% | +0.5 points |
CHTR's operating margin was −24% last quarter, down 47 points from the same quarter a year ago, near the bottom of its range since 2019.
META Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $64.6B | +26% |
| Q2 2026 | $60.8B | +28% |
| Q1 2026 | $56.3B | +33% |
| Q4 2025 | $59.9B | +24% |
| Q3 2025 | $51.2B | +26% |
| Q2 2025 | $47.5B | +22% |
| Q1 2025 | $42.3B | +16% |
| Q4 2024 | $48.4B | +21% |
META has the edge over CHTR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | -20 points |
| Q2 2026 | 31% | -12 points |
| Q1 2026 | 41% | -0.9 points |
| Q4 2025 | 41% | -7 points |
| Q3 2025 | 40% | -2.7 points |
| Q2 2025 | 43% | +5 points |
| Q1 2025 | 41% | +3.6 points |
| Q4 2024 | 48% | +7.4 points |
META has the edge over CHTR on profitability, with a higher operating margin.
CHTR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1B | -30% |
| Q2 2026 | $1.1B | +45% |
| Q1 2026 | $1.4B | -21% |
| Q4 2025 | $426M | +7% |
| Q3 2025 | $1.4B | +6.5% |
| Q2 2025 | $726M | -27% |
| Q1 2025 | $1.8B | +336% |
| Q4 2024 | $398M | -60% |
CHTR has the edge over META on cash flow, with more consistent year-over-year improvement.
META Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -110% |
| Q2 2026 | $1.7B | -81% |
| Q1 2026 | $13.2B | +19% |
| Q4 2025 | $14.8B | +9.3% |
| Q3 2025 | $11.2B | -32% |
| Q2 2025 | $9B | -19% |
| Q1 2025 | $11.1B | -14% |
| Q4 2024 | $13.6B | +16% |
META usually generates cash, though not every quarter: the latest was −$1.2B, but it generated $28.6B over the past year.
CHTR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -3.6% | -4.3M shares |
| 1 year | -14% | -19.5M shares |
| 3 years | -23% | -35.1M shares |
| 5 years | -38% | -70.2M shares |
| Available history | -46% | -101M shares |
CHTR has the edge over META on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $21M |
| Q2 2026 | $852M |
| Q1 2026 | $1B |
| Q4 2025 | $766M |
| Q3 2025 | $2.1B |
| Q2 2025 | $1.5B |
| Q1 2025 | $802M |
| Q4 2024 | $114M |
CHTR spent $2.7B buying back its own shares over the past year, down 41% from the year before.
META Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +7M shares |
| 1 year | 0% | +1M shares |
| 3 years | -2.6% | -68M shares |
| 5 years | -10% | -286M shares |
| Available history | -11% | -303M shares |
META has 2.6B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $3.3B |
| Q2 2025 | $10.2B |
| Q1 2025 | $12.8B |
| Q4 2024 | — |
META hasn't bought back shares in the past year.
CHTR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.0x | High |
| Q2 2026 | 4.4x | High |
| Q1 2026 | 4.3x | High |
| Q4 2025 | 4.4x | High |
| Q3 2025 | 4.4x | High |
| Q2 2025 | 4.3x | High |
| Q1 2025 | 4.3x | High |
| Q4 2024 | 4.3x | High |
CHTR's net debt is about 7.0 years of its operating earnings (EBITDA), up from 4.4 years a year ago.
META Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.6x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.2x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.0x | Very low |
| Q4 2024 | -0.2x | Net Cash |
META has the edge over CHTR on leverage, with a lower net debt burden relative to earnings.
CHTR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.5 | Neutral |
| Stochastic | 32.9 | Neutral |
CHTR's weekly RSI is 47 (neutral) and its Stochastic is 33 (neutral).
META Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.2 | Neutral |
| Stochastic | 33.7 | Neutral |
META's weekly RSI is 48 (neutral) and its Stochastic is 34 (neutral).
CHTR PE vs Communication Services Sector
| Metric | CHTR | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 16x | 16% below |
| PE % | 57 | 26 | 31 pts above |
CHTR has the edge over META on valuation relative to its sector.
META PE vs Communication Services Sector
| Metric | META | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 16x | 29% above |
| PE % | 18 | 26 | 8 pts below |
META is trading at 21x earnings, a 29% premium to the Communication Services sector's median of 16x.
CHTR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $113.3 | 17% above |
| 20 week MA | $130.5 | 1.6% above |
| 50 week MA | $168.2 | 21% below |
| 100 week MA | $247.3 | 46% below |
| 200 week MA | $300.4 | 56% below |
CHTR has the edge over META on trend strength, trading above more of its moving averages.
META Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $674.9 | 7.6% below |
| 20 week MA | $634.5 | 1.7% below |
| 50 week MA | $630.8 | 1.1% below |
| 100 week MA | $647.8 | 3.7% below |
| 200 week MA | $517.5 | 21% above |
META has fallen below most of its moving averages, though it's still 21% above its 200-week average.
CHTR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $483.7 | $656.5 | +36% |
| 2021 | $656.5 | $648.3 | -1.2% |
| 2022 | $648.3 | $333.9 | -48% |
| 2023 | $333.9 | $388.7 | +16% |
| 2024 | $388.7 | $348.7 | -10% |
| 2025 | $348.7 | $207.2 | -41% |
| 2026 YTD | $207.2 | $132.7 | -36% |
CHTR has finished lower in four of the last six years. It's down 36% so far in 2026.
META Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $208.1 | $267.4 | +28% |
| 2021 | $267.4 | $335.2 | +25% |
| 2022 | $335.2 | $118.0 | -65% |
| 2023 | $118.0 | $354.0 | +200% |
| 2024 | $354.0 | $599.8 | +69% |
| 2025 | $599.8 | $663.3 | +11% |
| 2026 YTD | $663.3 | $623.6 | -6% |
META has the edge over CHTR on returns for 2026, with the stronger performance.